Cellectis announced the appointment of Bing C. Wang, PhD, MBA, as member of its executive committee. Dr. Wang is a highly accomplished biotechnology executive who brings extensive global finance experience in the biotechnology industry including a background with global public companies in corporate finance, mergers and acquisitions, operations management systems, and financial planning and analysis. He joins the company to oversee the company's global finance team reporting directly to Chief Executive Officer, André Choulika, PhD.

Prior to joining the company, Dr. Wang was most recently the Chief Executive Officer and Director of Refuge Biotechnologies Inc., which he co-founded following nearly a decade of healthcare investment banking experience. Prior to his tenure at Refuge, Dr. Wang worked in healthcare investment banking at Barclays Capital Inc. and Citigroup Global Markets Inc.